Raymond James Financial Services Advisors’s TG Therapeutics TGTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
$2.55M Sell
108,969
-304
-0.3% -$7.11K ﹤0.01% 1603
2024
Q2
$1.94M Buy
109,273
+1,853
+2% +$33K ﹤0.01% 1682
2024
Q1
$1.63M Buy
107,420
+4,548
+4% +$69.2K ﹤0.01% 1749
2023
Q4
$1.76M Buy
102,872
+4,011
+4% +$68.5K ﹤0.01% 1640
2023
Q3
$826K Sell
98,861
-4,715
-5% -$39.4K ﹤0.01% 2020
2023
Q2
$2.57M Buy
103,576
+1,291
+1% +$32.1K ﹤0.01% 1380
2023
Q1
$1.54M Buy
102,285
+3,696
+4% +$55.6K ﹤0.01% 1644
2022
Q4
$1.17M Sell
98,589
-659
-0.7% -$7.8K ﹤0.01% 1735
2022
Q3
$588K Sell
99,248
-1,918
-2% -$11.4K ﹤0.01% 2149
2022
Q2
$430K Sell
101,166
-12,187
-11% -$51.8K ﹤0.01% 2363
2022
Q1
$1.08M Buy
113,353
+987
+0.9% +$9.39K ﹤0.01% 1893
2021
Q4
$2.14M Sell
112,366
-30
-0% -$570 ﹤0.01% 1497
2021
Q3
$3.74M Sell
112,396
-3,147
-3% -$105K 0.01% 1126
2021
Q2
$4.48M Sell
115,543
-4,415
-4% -$171K 0.01% 1026
2021
Q1
$5.78M Sell
119,958
-3,435
-3% -$166K 0.01% 839
2020
Q4
$6.42M Buy
123,393
+4,400
+4% +$229K 0.02% 728
2020
Q3
$3.18M Sell
118,993
-6,807
-5% -$182K 0.01% 955
2020
Q2
$2.45M Sell
125,800
-6,823
-5% -$133K 0.01% 1021
2020
Q1
$1.31M Sell
132,623
-27,826
-17% -$274K 0.01% 1078
2019
Q4
$1.78M Buy
160,449
+6,745
+4% +$74.9K 0.01% 1222
2019
Q3
$863K Sell
153,704
-242
-0.2% -$1.36K ﹤0.01% 1556
2019
Q2
$1.33M Sell
153,946
-10,533
-6% -$91.1K 0.01% 1330
2019
Q1
$1.32M Buy
164,479
+21,139
+15% +$170K 0.01% 1295
2018
Q4
$588K Sell
143,340
-2,255
-2% -$9.25K ﹤0.01% 1566
2018
Q3
$815K Buy
145,595
+1,359
+0.9% +$7.61K ﹤0.01% 1589
2018
Q2
$1.9M Buy
144,236
+5,165
+4% +$67.9K 0.01% 1053
2018
Q1
$1.98M Buy
139,071
+687
+0.5% +$9.76K 0.01% 938
2017
Q4
$1.14M Buy
138,384
+57,280
+71% +$470K 0.01% 1219
2017
Q3
$961K Buy
81,104
+31,958
+65% +$379K 0.01% 1338
2017
Q2
$494K Buy
49,146
+4,240
+9% +$42.6K ﹤0.01% 1681
2017
Q1
$523K Buy
44,906
+14,068
+46% +$164K ﹤0.01% 1540
2016
Q4
$143K Buy
+30,838
New +$143K ﹤0.01% 2133